Covered recipient · General Payments record
CARL DANIEL PATE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$4,596.07
- Reported across 318 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $545.35 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $161.61 | 16 |
| PFIZER INC. | $93.06 | 2 |
| Lilly USA, LLC | $90.44 | 6 |
| Novo Nordisk AS | $49.76 | 3 |
| Merck Sharp & Dohme Corporation | $29.71 | 2 |
| GlaxoSmithKline, LLC. | $28.02 | 2 |
| Medtronic, Inc. | $25.64 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $23.45 | 1 |
| Phathom Pharmaceuticals, Inc. | $16.87 | 1 |
| Astellas Pharma US Inc | $13.55 | 1 |
| Amgen Inc. | $13.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.27 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105189761 | CMS |
| ABBVIE INC. | $4.79 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105189763 | CMS |
| ABBVIE INC. | $10.24 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105189765 | CMS |
| ABBVIE INC. | $15.65 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105189767 | CMS |
| ABBVIE INC. | $8.49 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105189769 | CMS |
| ABBVIE INC. | $3.18 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105189771 | CMS |
| ABBVIE INC. | $18.59 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105189773 | CMS |
| ABBVIE INC. | $3.09 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105189775 | CMS |
| ABBVIE INC. | $6.42 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105189777 | CMS |
| ABBVIE INC. | $33.42 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105189779 | CMS |
| ABBVIE INC. | $14.60 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105189781 | CMS |
| ABBVIE INC. | $2.62 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105189783 | CMS |
| ABBVIE INC. | $12.62 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105189785 | CMS |
| ABBVIE INC. | $2.27 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105189787 | CMS |
| ABBVIE INC. | $7.88 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105189789 | CMS |
| ABBVIE INC. | $1.48 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105189791 | CMS |
| Amgen Inc. | $13.24 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117348055 | CMS |
| Astellas Pharma US Inc | $13.55 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139290214 | CMS |
| GlaxoSmithKline, LLC. | $14.62 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116711507 | CMS |
| GlaxoSmithKline, LLC. | $13.40 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116342594 | CMS |
| Lilly USA, LLC | $16.92 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136034420 | CMS |
| Lilly USA, LLC | $16.48 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136080712 | CMS |
| Lilly USA, LLC | $13.76 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136087690 | CMS |
| Lilly USA, LLC | $13.91 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136084804 | CMS |
| Lilly USA, LLC | $15.16 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136034422 | CMS |
| Lilly USA, LLC | $14.21 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136084184 | CMS |
| Medtronic, Inc. | $25.64 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119276446 | CMS |
| Merck Sharp & Dohme LLC | $13.52 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141629958 | CMS |
| Merck Sharp & Dohme LLC | $16.19 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141845959 | CMS |
| Novartis Pharmaceuticals Corporation | $23.45 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087254273 | CMS |
| Novo Nordisk Inc | $16.77 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096628589 | CMS |
| Novo Nordisk Inc | $16.22 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097272688 | CMS |
| Novo Nordisk Inc | $16.77 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096719102 | CMS |
| PFIZER INC. | $71.06 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131482904 | CMS |
| PFIZER INC. | $22.00 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131624834 | CMS |
| Phathom Pharmaceuticals, Inc. | $16.87 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151106734 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.